Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, $0.001 par value per share · CUSIP: 252828108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 3,866,733.00 · Class: 9.5%

  • Peter Kolchinsky

    Shares: 3,866,733.00 · Class: 9.5%

  • Rajeev Shah

    Shares: 3,866,733.00 · Class: 9.5%

  • RA Capital Healthcare Fund, L.P.

    Shares: 3,866,733.00 · Class: 9.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-25-000486
Form type
SCHEDULE 13G/A
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub